Internal Medicine · San Mateo, CA
NPI
1164697728
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
100 S Ellsworth Ave Ste 208
San Mateo, CA, 94401
Phone (650) 343-8512
Groups this clinician bills Medicare through
Medicare paid, 2024
$218K
2,526 services
Medicare patients, 2024
525
Average age 80
Drug cost, 2024
$2.3M
18,221 prescriptions
Company payments, 2025
$1,683
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dina Sverdlov was code 99213 (office e&m - established), 741 times for 393 patients. In total Dina Sverdlov billed 2,526 services in 17 codes, and Medicare paid $218K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 741 | 393 | $81.66 | $61K |
| 99212 Office E&M - Established | Office | 564 | 286 | $52.36 | $30K |
| 99214 Office E&M - Established | Office | 468 | 332 | $111.98 | $52K |
| 99497 Care Management/Coordination | Office | 239 | 236 | $69.81 | $17K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 224 | 224 | $147.75 | $33K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 65 | 65 | $22.81 | $1,483 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 65 | 65 | $22.81 | $1,483 |
| 99215 Office E&M - Established | Office | 63 | 60 | $151.93 | $9,572 |
| 93000 Electrocardiogram | Office | 32 | 32 | $13.19 | $422 |
| 99205 Office E&M - New | Office | 19 | 19 | $180.49 | $3,429 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 18 | 18 | $258.15 | $4,647 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 12 | 11 | $191.06 | $2,293 |
By year: 2022 $314K for 3,926 services; 2023 $293K for 3,647 services; 2024 $218K for 2,526 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dina Sverdlov prescribed most often to Medicare patients was Gabapentin, with 759 prescriptions and refills. In total Dina Sverdlov wrote 18,221 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 759 | 1,162 | 200 | $6,751 |
| Levothyroxine Sodium Generic | 730 | 1,440 | 129 | $4,831 |
| Amlodipine Besylate Generic | 693 | 1,466 | 176 | $2,127 |
| Famotidine Generic | 615 | 1,183 | 168 | $4,682 |
| Rosuvastatin Calcium Generic | 549 | 1,214 | 146 | $10K |
| Atorvastatin Calcium Generic | 499 | 978 | 121 | $2,618 |
| Creon Lipase/Protease/Amylase | 396 | 424 | 67 | $363K |
| Escitalopram Oxalate Generic | 364 | 617 | 82 | $2,187 |
| Metoprolol Succinate Generic | 355 | 734 | 86 | $3,109 |
| Metformin Hcl Generic | 355 | 705 | 84 | $1,489 |
| Pantoprazole Sodium Generic | 347 | 767 | 99 | $3,688 |
| Losartan Potassium Generic | 303 | 614 | 70 | $1,962 |
| Lisinopril Generic | 291 | 647 | 72 | $1,119 |
| Eliquis Apixaban | 283 | 466 | 53 | $277K |
| Olmesartan Medoxomil Generic | 278 | 408 | 42 | $1,695 |
Brand drugs: 3,390 claims; generic drugs: 14,702 claims; opioid claims: 115.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dina Sverdlov $1,683 ($1,683 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $699.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 24 | $699 |
| Novo Nordisk Inc NVO | 8 | $195 |
| Lilly USA, LLC LLY | 6 | $152 |
| GlaxoSmithKline, LLC. GSK | 4 | $104 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $100 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $85.87 |
| Exact Sciences Corporation EXAS | 3 | $68.43 |
| Aimmune Therapeutics, Inc. | 2 | $47.26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $35.14 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $33.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.